🇺🇸 Metformin cloridrate in United States
18 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 18
Most-reported reactions
- Hypoglycaemia — 6 reports (33.33%)
- Hyperhidrosis — 2 reports (11.11%)
- Hypoglycaemic Coma — 2 reports (11.11%)
- Lactic Acidosis — 2 reports (11.11%)
- Alanine Aminotransferase Increased — 1 report (5.56%)
- Altered State Of Consciousness — 1 report (5.56%)
- Aspartate Aminotransferase Increased — 1 report (5.56%)
- Chills — 1 report (5.56%)
- Confusional State — 1 report (5.56%)
- Dysarthria — 1 report (5.56%)
Other Diabetes approved in United States
Frequently asked questions
Is Metformin cloridrate approved in United States?
Metformin cloridrate does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Metformin cloridrate in United States?
University Magna Graecia is the originator. The local marketing authorisation holder may differ — check the official source linked above.